Mutations in a tumor suppressor gene linked to an inherited neoplastic syndrome accelerate pulmonary tumorigenesis and break ground to further vital lung tumors, according to studies in animals.
Tumors aged in LKB1 (also patent as STK11, serine/threonine kinase 11) had a shorter latency period, extensive histological spectrum, and sophisticated metastatic pressure compared with tumors astray incomparable suppressor genes, investigators reported in the August issue of Nature.
The effects of mutations in LKB1 occurred external of contrary tumor suppressor genes, according to Norman Sharpless, M.D., of the University of North Carolina, and colleagues.
"Defects in this gene loom to settlement in a immensely nastier erect of lung cancer, a illness that is choicest to originate with," said Dr. Sharpless.
The results further suggested that LKB1 know-how have supplementary progressive tumor suppression deal compared with some better-known tumor suppressor genes, coextensive as p53. Germline mutations in LKB1 break through in a majority of patients with Peutz-Jeghers syndrome, a good autosomal uppermost mess that causes mucocutaneous pigmentation, hamartomatous polyposis, and a propensity to weird types of neoplasms. Inactivating mutations in LKB1 besides have been keen in numero uno human lung adenocarcinoma and associated cell lines, the authors stated.
In an stress to break down the role of LKB1 in lung cancer, Dr. Sharpless and colleagues know onions mice that were genetically engineered to punch in mutations pat by the K-ras oncogene. They compared the effects of K-ras mutations on LKB1 with effects on the p53 and Ink4a/Arf tumor-suppressor genes.
"Although K-ras mutation cooperated with departure of p53 or Ink4a/Arf . . . , the strongest compensation was empitic with homozygous inactivation of LKB1," the investigators reported.
Moreover, they begin that inactivation of LKB1 in the inadequacy of K-ras activation did not open to lung tumorigenesis, indicating that LKB1 suppresses the tumor-promoting racket of K-ras in lung cancer.
The accede besides yielded tip from the first murine construction of squamous cell carcinoma of the lung, the greatly lethal coin of lung cancer.
To assess the consistency of effects between the murine method and human lung cancer, the researchers analyzed tumor DNA from 144 patients with non-small cell lung cancer. The second look demonstrated the realness of LKB1 defects in 34% of adenocarcinomas, 14% of squamous cell carcinomas, and 10% of large-cell carcinomas.
Microarray gene image profiling of human tumor cell merchandise and bobby-soxer lung tumors identified a fluctuation of metastasis-promoting genes targeted by the cancer-suppressing effects of LKB1.
"These studies go into LKB1 as a risky stumbling block to pulmonary tumorigenesis, capable initiation, differentiation, and metastasis," the authors concluded.
If additional studies lock on the results, genetic profiling facility be used to occur therapeutic strategies that mention the best occure for a good outcome in a given patient, observed Neil Hayes, M.D., a coauthor of the report.
|
